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Abstract
Eutectic systems, including eutectic salts, deep eutectic solvents, and eutectic molecular mixtures, have recently been
shown to have enormous potential in a number of technological and scientiﬁc endeavors. Eutectic mixtures, along with
other binary systems including solid dispersion, cocrystals, and inclusion complexes, could be used simultaneously to
improve a number of drugs, including stability, permeability, and dissolution. Over the past few years, their usefulness
in the pharmaceutical ﬁeld has expanded. On a laboratory scale and an industrial scale, eutectics could be produced quite
readily (and occasionally spontaneously). In order to fully utilize eutectics in the pharmaceutical industry, it is essential
to understand their preparation process, characteristics, and evaluation criteria as well as how they affect drug dissolution.
Keywords: Carrier, Eutectic mixtures, Phase diagrams, Crystal lattice

1. Introduction

T

he majority of solid active pharmaceutical ingredients (APIs) have issues with polymorphism, inadequate bioavailability, insufﬁcient
dissolution, and, ultimately, treatment effectiveness.
Many methods based on deep eutectic solvents
(DES) and eutectic mixtures were calculated to get
around such restrictions [1]. Eutectic salts, eutectic
metals, and deep eutectic solvents are the three
common categories of eutectics. They are all eutectic
systems, and they share the same eutectic principle.
Problematic organic solvents are employed in the
formulation of many drugs, and researchers are
working to develop more benign alternatives. DESs
are frequently mistakenly classed as a subclass of
ionic liquids (ILs) because of the physical similarities between the two substances [2]. Yet, DESs are
combinations of natural molecules as opposed to
ILs, which are made up of a pair of an inorganic or
organic anion and large asymmetric organiccations.
High viscosity, low vapor pressure, non-

ﬂammability, low cost, biodegradability, and low
toxicity, a wide liquid range, the capability of dissolving a variety of solutes, as well as thermal and
chemical stability, are shared by the two distinct
types of solvents [3]. In spite of having many of the
same features as ILs, DESs have certain advantages
over them, such as a lack of water reactivity, no or
low toxicity, ease of synthesis, biodegradability, and
affordable and easily accessible ingredients, which
suggests DEM as ﬂexible substitutes [4].
The majority of problems that arose in the
administration of many (APIs) with limited solubility, insufﬁcient bioavailability, poor stability, and
polymorphism, as well as formulation issues, were
exacerbated by EM. Additionally, EM enhanced the
skin permeation regarding topical formulations of
poorly soluble drugs, which can be beneﬁcial for the
local treatment of a number of infections and more
beneﬁcial through offering fewer side effects, quick
drug delivery to target site, and higher drug
amounts in the tissues [5]. These problems highlight
the urgent necessity for the creation of a eutectic
mixture (EM) dosage form for pharmaceuticals. A
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mixture of at least two substances that, in most
cases, do not combine to produce new chemical
compounds but, at speciﬁc ratios, prevent one
another from crystallizing, leading to a system with
a lower melting point compared to any components,
is referred to as a EM. Eutectic temperature is the
temperature at which the system is in the liquid
phase. Above this temperature, the components
exist as a liquid, and below this temperature, they
are solids or combined into a multi-component
compound made up of at least two crystalline solids
which show immiscibility in the solid state and don't
combine in order to create a new chemical complex.
However, at a speciﬁc ratio, the eutectic composition
will show a melting or solidiﬁcation point considerably lower than its constituents [6,7].
At the eutectic composition, the two components
exhibit a reduction in particle size and are evenly
disseminated, which helps to increase the drug's
bioavailability and dissolution rate [8]. By boosting
entropy and elucidating the melting point depression, it is clear and simple to comprehend [9]. EM
could form between excipients, between excipients
and APIs, or between APIs. This allows for a wide
range of applications in pharmaceutical formulations [10]. The word is a combination of the Greek
words “eu,” meaning “easy,” “well,” “good,” and
“tecsis,” meaning “melting.” A highly effective and
encouraging method for monitoring the polymorphism and aqueous solubility of solid drugs is
the use of the eutectic mixture. APIs that involve EM
should have better biopharmaceutical and physicochemical properties than solid or crystalline APIs
[11]. A superlattice mixture known as a eutectic
mixture is one that either melts or solidiﬁes at lower
degree of the temperature compared to melting
point of any one of the constituent compounds. It
is a solid homogeneous mixture made of a
minimum of two solid components that produces
change of phase to liquid at some speciﬁc temperature. It is frequently indicated as an alloy mixture
(Fig. 1) [12].

2. Characteristics are typically responsible for
EM formation
(1) components should be immiscible in the solid
state and generally miscible in a liquid state
(2) The contact-induced melting point depression
requires close contact between the eutectic
forming materials.
(3) Physical bonds, for example, intermolecular
hydrogen bonding, resulted from interaction
among two-chemical groups

(4) molecules that are in accordance with the
modiﬁed VantHoff equation has the ability of
forming the eutectic mixes [13].
Concerning eutectic temperature; that remains
the lowest melting temperature unrelatedly of the
compositional ratios. When a superlattice reaches
this temperature, all of the components will start to
evaporate, and the mixture will be melted. As
opposed to a eutectic mixture, in a non-eutectic
mixture, each portion solidiﬁes into a lattice at its
temperature before the whole mix solidiﬁes [8].
Eutectic compositions are formed using the geometric dilution method and are made up of at least
two elements of the same melting and freezing
properties. The mixture is created by the crystallization process, allowing the product to behave as a
unit. The materials can form a dense crystal network
and melt together simultaneously, with no distinction. EM has many advantages like (a) low cost (b)
chemically inert with water (c) easy to prepare due
to the fact that they're obtained from the simple
mixing of 2 components, as a consequence bypassing all waste disposal and puriﬁcation problems that
encountered with ILs and (d) they are biodegradable, bio-compatible and non-toxic, highlighting the
greenness of these media [14].

3. Methods of preparation
The main approaches for the preparation of the
deep eutectic solvents are heating approach, solvent
evaporation and the Grinding approach [15].
3.1. Melting (heating) approach
Obi and Sekiguchi, who prepared a physical
mixture of sulfathiazole and urea, were the ﬁrst to
use this technique. In order to produce supersaturation of the mixture, the technique entailed heating
the components until they melted. The molten
mixture then settled quickly with constant stirring at
a low temperature while employing an ice bath.
These conditions cause substance molecules to
become “trapped” in the matrix of a system that is
quickly solidifying. To standardize the size of the
grains obtained, the solid mass generated is pulverized then sieved. This method improves the
crystals' dispersion within the EM [16]. This technique has so far been utilized to create EMs of urea
with chloramphenicol and acetaminophen [17]. This
method has recently been used to create EMs of
benznidazole and Posaconazole, which typically call
for an additional step like grinding and sieving to
minimize particle size. It is well known that
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Fig. 1. Diagram representing the phases of two components' scheme [12].

throughout the heating process, molecule mobility
and reorganization lead to weak intermolecular interactions in a eutectic [18]. Despite being widely
used the fusion approach has certain drawbacks.
Only when the drug substance and the carrier
combine homogeneously after heating could it be
used, according to E. Zaini et al. 2015 for ketoprofen.
The fact that both the drug substance and the carrier
degrade at high temperatures is a signiﬁcant
restriction of this approach. A volatile drug or a
carrier might evaporate as a result of heating.
Heating or melting the mixture in a vacuum is one
method for resolving this issue. Additionally, the
procedure might be carried out in an environment
where inert gasesdlike nitrogendprevent the drug
or carrier from degrading due to oxygen. Phase
separation results from a change in the components'
mutual miscibility during cooling, which is another
undesirable aspect of this approach. The mixture
slowly cooled, and it was then possible to see the
drug crystallizing. However, quick cooling encourages the development of amorphous solid dispersions [6].
3.2. Grinding method (Mechanical methods)
On a laboratory scale, this approach is utilized for
the preparation of the eutectic mixes. The function
of grinding can be performed by using a mortar
pestle, while in large-scale, vibratory mills [19],
mechanical grinders are used. This method has

some drawbacks, so this is not used conventionally
[20]. By Mechanical grinding of the binary components, breaking bonds resulted on account of the
shearing and stress, which exposes reactant
surfaces’ area and reorganization via the transformation of the bulk phase into the micro-structures. Accommodating counter molecules could
result in arbitrarily ordered arrangement with the
weak non-covalent forces. Those weaker attractive
forces need less amount of the activating energy to
melt at lower degree of the temperature (i.e. eutectic
melt) and it conveys sufﬁcient thermo-dynamic
stability of the eutectic mixes [21]. The pressure of
grinding through breaking and making hydrogen
bonds frequently encourages the cocrystal formation, but in the case where there is incompatibility
or lack of the secondary interactions to produce
stable lattice structure, the product will result in
simple eutectic composition [18].
3.3. Solvent evaporation method
In this method, an in situ eutectic mixture was
formed using three or more substances with lower
alkyl esters of p-hydroxybenzoic acid. It was ﬁrst
used by Tachbani and Nakamura by preparing solid
dispersion of lipophilic b-carotene in PVP as a hydrophilic carrier, by dissolving both drug and a
carrier in a volatile solvent, such as chloroform or
dichloromethane. Then by complete evaporation of
solvent at 23e65  C, and the resulting ﬁlm was dried
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and pulverized [18]. The solvent type and the rate of
removal are essential factors in determining the
dissolution rate of drug substances in solid dispersion obtained. They affect the crystallographic
structure of the resulting system. The advantage of
this method is preventing the degradation of the
drug substance by maintaining the low temperature
needed for solvent evaporation. The disadvantages
include high cost of production, difﬁculties with the
selection of volatile solvent to be completely
removed, chemical stability of the substance,
besides the problem with the reconstruction of the
crystalline form [18,22].

4. Dissolution rate enhancement mechanism
by eutectic mixtures
Throughout solubility improvement, the Dissolution rate enhancement will result from the use of a
eutectic mixture when coming in contact with the
gastrointestinal ﬂuids due to the immediately dissolving of the insoluble drug which is left in a very
ﬁne subdivision state.
1 E. Zaini and colleagues 2015, tested the dissolution properties of pure ketoprofen and eutectic
mix (0.6:0.4 M fraction) in phosphate buffer (pH
7.4). An EM of ketoprofen and nicotinamide
(0.6:0.4 M fraction) revealed a better proﬁle of
the dissolution rate than intact ketoprofen. At
30 min, the amount of pure ketoprofen that had
been dissolved was 77.94 ± 0.91%, while the
amount of ketoprofen that had been dissolved
from the eutectic mixture reached 100.65 0.89.
Sekiguchi and coworkers in 1961 reported the
same thing [16]. The preparation with EM has a
longer shelf life because it keeps the formulation
from hydrolyzing. The EM has higher stability
than other solid formulations due to its crystalline structure [7,15].
2 Park CW et al. 2012, examined the phase behaviors of the itraconazoleephenol mixes and
evaluated feasibility of the topical formulations
of the itraconazole utilizing the eutectic mix
systems. Despite the high log partition coefﬁcient and the high molecular weight of the Itraconazole, the results indicate a potential of the
itraconazole for topical delivery utilizing
itraconazoleephenol eutectic system for the
enhancement of the permeation of the skin. [5].
3 Figueir^
edo CB et al. 2017, Report formation of
eutectic mix in addition to amorphous solid
solution of PCZ and BNZ (at a characteristic ratio
of 80:20wt%) that had provided improved solubility and dissolution rate for the two APIs.

Utilizing 3 approaches of the preparation of
those binary pharmaceutical BNZ and PCZ
compositions:
1 Evaporative crystallization method.
2 Alternative approach for the generation of
the crystalline eutectic mix.
3 Hot melt and cooling approach.
Different PCZ to BNZ ratios (96:04, 90:10, 80:20,
70:30, 60:40, 50:50, 40:60, 30:70, 20:80, and 10:90w/w
%, respectively) have been combined and dissolved
in 100% ethyl alcohol to produce PCZ/BNZ mixtures. A white or off-white crystalline powder was
produced by solvent being evaporated at 50 _C for
around 1 h. The obtained eutectic crystalline PCZ/
BNZ mixes were further ground to decrease the
particle size, and resulting powder with particle
sizes between (75 mme150mm) was collected with
the use of a mini sieve for further characterization.
The results showed that the eutectic mixture had
higher rate of the dissolution than the API alone
[23].
4 Bazzo GC and coworkers 2019, pointed out that
There has been an increase in solubility of Efavirenz (EFZ) in water in presence of a hydrophilic drug, tenofovir disoproxil fumarate (TDF),
on solubility and dissolution rates of poorly
water-soluble drug EFZ, that may be utilized in a
simultaneous manner in treating human
immuno-deﬁciency virus type-1 infection. It has
been evident that TDF solubility strongly impacts EFZ solubility in various media, being EFZ
solubility favored in acidic medium and reduced
in the phosphate buffer pH 6.8. However, the
TDF solubility has not been affected by EFZ.
Additionally, both drugs form eutectic mixt,
especially in molar ratio of EFZ/TDF (65/35) that
resulted in improving the solubility and dissolution rate of EFZ in an acidic medium through a
simple technique of mixing, in deﬁned proportions, without the need for other technological approaches [24].
5 Additionally, Park H. et al. 2020, formulation of
glimepiride and L-arginine (GA) as binary mixtures in 2020, using a variety of molar ratios to
keep the medicinal material in a crystalline state,
has the speciﬁc advantage of being thermodynamically stable. Raised wettability and the
development of a microenvironment where glimepiride's solubility was increased due to a high
local concentration of the hydrophilic reagent in
the surrounding solution can both be used to
explain why eutectic mixtures have improved
dissolution capabilities. The dissolution proﬁles
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regarding samples of a powdered GA mixture
performed in a phosphate buffer at pH 6.8 [25].
Using differential scanning calorimetry, Maasoi
C. et al. 2021, developed and examined the role
of the formulation of bromazepam and citric acid
as binary mixtures and drug dissolution in oral
absorption. Increased bromazepam dissolution
rate and improved therapeutic efﬁcacy of the
active pharmaceutical ingredient are advocated
by the mixture's eutectic [26].
Hyun SM et al. 2019, studied the formulation of
eutectic mixtures, as binary pharmaceutical
compositions of the Celecoxib (CEL) with
saccharin (SAC) and adipic acid (ADI), which
have been identiﬁed via phase diagram that has
been intended for the improvement of wettability and dissolution rates of the poorly watersoluble Celecoxib. This study has shown that
contact angles at 0's in liquidesolid interface
have been almost qs (theta) 79.70 ± 0.50 and
86.65 ± 0.45 for the CEL-ADI and CEL-SAC,
respectively, which have been considerably
lower compared to value that has been obtained
for the CEL (92.05 ± 0.75oq) which revealed that
the rate of the dissolution gas been increased
with the decrease of the contact angle [27].
Additionally, Kim D. et al. 2021, has a speciﬁc
goal to create a naproxen (NPX) eutectic mixture
with an API greater than 20 wt%. The maximum
NPX content was only approximately 15% wt%,
rendering eutectic compositions impractical
through restricting the NPX dose to <150 m,
assuming the upper limit of the mixture is
considered to be 1000 mg. Cases of naproxen
eutectic formation were infrequently documented (particularly with small molecules) [28].
A number of EMs of fatty acids were created by
Parveen F. 2022 and colleagues as natural supplies with exceptional, alluring physicochemical
characteristics, such as stability, security, availability, affordability, and compatibility with
healthy human cells. The reversible solideliquid
phase transition is in charge of holding the drug
in place or causing it to be actively released. To
create a tunable thermoresponsive platform,
liquid lipid (oleic acid) and eutectic mixes of fatty
acids (myristic acid and stearic acid) have been
combined. With the help of a combination of the
hot melt encapsulation (HME) and sonication
methods, doxorubicin-loaded lipid nanocarriers
have been efﬁciently created, and they were
then characterized for achieving improved

57

permeability and retention (EPR) effect-based
solid tumor targeting in response to exogenous
temperature stimulus. The resulting Doxorubicin-loaded lipid nanocarriers show exceptional
colloidal stability, a spherical shape, a limited
size distribution (94.59 nme219.3 nm), and a PDI
(0.16e0.479). The developed Z.P value ranges
from 22.7 to 32. The tunable thermoresponsive
properties of lipid nanocarriers make them
promising bio-compatible drug delivery systems
for more effective targeted delivery of chemotherapeutic agents [29].
10 Through the use of salicylic acid as a conformer
during the eutectic formation, Narwal S. 2021
and his team enhanced the medication curcumin's poor water solubility. When compared to
pure curcumin, in-vitro dissolution studies for
the eutectic mixture (69.38%) showed enhanced
dissolution behavior (40.53%) [30].
11 In the case when the mixture was characterized,
it was discovered that PEG and fenoﬁbrate form
a simple eutectic mixture with 20e25% (w/w)
fenoﬁbrate at the eutectic point. Law D. and
coworkers 2003 studied the enhancement
regarding the dissolution rate of a poorly soluble
compound through the formation of PEG-drug
eutectics using fenoﬁbrate. Fenoﬁbrate crystals
were discovered to be < 10 microns in size as a
result of eutectic crystallization, which produced
an uneven microstructure. The phase diagram
and the fenoﬁbrate dissolution rate improvement were both related, and the amount
of fenoﬁbrate released from the eutectic
mixture containing fenoﬁbrate was at least ten
times greater than that of untreated fenoﬁbrate
[31].

5. Characterization of the eutectic mixtures
Predicting the formation of eutectics is considered a challenging process since the depression in
melting point by thermal methods is the only indicator of eutectic formation. In addition, the
phase diagram will show the extent of solidesolid
solubility, and the eutectic composition. Spectroscopy and powder x-ray diffraction is
commonly used for the prediction of multicomponent solids like salts and cocrystals. Eutectic
mixtures do not show any change in spectroscopic
and x-ray diffraction patterns when compared to
their individual components. Eutectic mixtures
show minor changes in spectral peaks and x-ray
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diffraction. Therefore, thermal analysis is the
best method for the prediction of eutectics. SEM
analysis is done for the particle size determinations [7].
5.1. Differential scanning calorimetry (DSC)
DSC technique is used to investigate the phase
change temperature (Tfus) and enthalpy of fusion
(DfusH ) indicating the eutectic phases. The thermogram of the eutectic mixture indicates the melting
point which lies between the melting point of the
drug and Coformer and as a result of higher entropy
and weaker interactions of non-random products,
the melting point of the eutectics will be lowered. In
this technique, the physical mixture is heated in a
DSC pan at a rate of heating 50 C/min, then upon
grinding, the formation of the eutectic phase
occurred, by increasing the temperature the
breaking and reorganization of bonds occurred
leading to the formation of eutectic phases. By DSC
we can indicate that eutectic formation is enhanced
by grinding. DSC thermograms show a classical “v”
shape in which the molar ratio is denoted at the
minimum point of “v” and this minimum point also
represents eutectic point [7,30e32].
5.2. Thermogravimetric analysis (TGA)
It is a thermal analysis technique that measured
the change in mass either loss or gain with respect
to temperature or time in a controlled atmosphere.
Mostly it is combined with other methods. The
composition of the material and thermal stability is
predicted by using TGA. It is an effective tool for the
determination of oxidative stability of drugs, lifetime of drug product, product decomposition analyses, the composition of a material, etc. [33].
5.3. Types of TGA
1 Isothermal or static thermogravimetry: Temperature is constant.
2 Dynamic thermogravimetry: Temperature is
changed in a linear manner.
3 Quasi Static thermogravimetry: A series of
increasing temperatures and the weight of the
sample is kept constant during the heating series
[30,33].
5.4. Powder x ray diffraction
The powder x-ray diffraction technique is used as
one of the conﬁrmatory tools for the

characterization and identiﬁcation of crystalline
material and detection of the formation of EM. On
the basis of wavelength of incident rays and angle
(ɵ) where constructive interferences occurred, the
tested material can be identiﬁed. Basically, spacing
between crystal lattice atoms can produce
constructive interferences which can be determined
by using Bragg's equation. In crystal structures there
are many planes of atoms, then the reﬂection from
all planes is used to determine the crystal structure.
[6,7,33].
PXRD results for EMs exhibit a pattern that is
comparable to that of the pure component. The
addition of a minor component that occurs as a
substitution in the major component only slightly
alters the XRD lines, and as a result, the molecular
arrangement in the crystal lattice (domain structure)
is mostly intact when put to comparison with the
individual components. In order to ensure that no
new peaks are seen and that the ground mixtures
contain all of the diffraction peaks of the initial
components [34,35] Atomic pair distribution function (PDF) analysis is another method that may be
used to examine the local structure of both amorphous and crystalline (nanocrystalline) solids. It is
based on real space ﬁtting for a pair of atoms
separated by a distance ‘r' [32,35].
It has the potential to be used to research the
eutectic microstructure. The Fourier Transform of
the PDF method incorporates the diffuse scattering
intensity along with the traditional Bragg reﬂections, making it sensitive to local structure
ordering. When compared to the typical crystallographic structure, PDF estimates the instantaneous
atomic arrangements and displays the local structure (low r region) [36,37].
5.5. FTIR spectroscopy
FTIR spectroscopy is used for the prediction of
intermolecular interactions and studying the
compatibility between the drug and the conformer. A
few milligrams of the sample are required for analysis
for solid. It is a fast technique and gives IR spectra that
resemble NMR correlation spectroscopy. In the
eutectic systems principle, a single phase formation is
commonly described as a basic association between
entities containing electron donor and electron
acceptor groups [33]. These groups bind together via
hydrogen bond formation mainly between the
hydroxyl group d OH of one compound with the
carbonyl group CO- of the other Which is identiﬁed
by the application of Fourier-transform infrared
(FTIR) spectroscopy analysis of the pure components
and their eutectic liquid [38]. In this regard, IR

MA'AEN JOURNAL FOR MEDICAL SCIENCES 2022;1:53e62

59

spectroscopy gives a response with respect to
changes in vibrational modes of covalent bonds due
to changes in intermolecular either stretching or
bending has been allocated to hydrogen bonding.
The information of molecular structure and dynamics
is given by 2D IR spectra. Eutectics can be differentiated from salts. In case of eutectics, there is a slight
change in the pattern of a spectral line in comparison
to the individual compounds [39,40].

coupled devices). The FT R is operated with NIR
laser, an interferometer and a semi conductor detector. Strong signals are given by the dispersive
spectrometer and minor component can be detected
by this device while FT R gives weaker signals, and
these are only applicable to quantitative analysis. In
case of eutectics there is slightly change in the
pattern of spectral line in comparison to the individual compounds [18,43].

5.6. Hot-stage microscopy (HSM)

5.8. Scanning electron microscopy (SEM)

HSM, which combines the thermal analysis
and microscopic approach, is utilized in the pharmaceutical industry to examine how the chemical and
physical properties of a material change with time
and temperature [18]. It is utilized to support DSC
and TGA observations as well as to identify small
changes in the sample that TGA and DSC could have
missed during a thermal experiment. In general,
HSM could be utilized to investigate the crystallization process, polymorphism, desolvation, melting
and boiling points, phase transitions, incompatibility,
and glass transitions between different medicinal
compounds [39,41]. In this method, observations are
made while a small number of substances are heated
and cooled on a microscopic slide. In either a closed
or open environment, the sample is heated in a sapphire crucible or glass slide. It may also be ﬁtted with
a liquid nitrogen unit for quick cooling, high pressure
pumps, or purge gas. A modern computer-controlled
hot stage has a temperature range of 200  Ce600  C
[41].

The morphological characteristics of EMs, like
particle shape, morphology, and size, which may be
linked with ﬂow parameters, were identiﬁed and
compared using SEM [18]. Emami et al. 2018,
investigated SEM to assess morphological variances
regarding succinic acid and glicazide EM which
were synthesized with the use of various methods.
SEM images demonstrated that the method used to
get EM had a substantial impact on the shape and
size of the glicazide particles. With the use of liquid
assistance in the grinding process, polydisperse
particles ranging in size from a few hundred nanometers to micrometers are produced. In contrast,
the electrospray deposition process created a
homogenous dispersion of submicron-sized particles that aggregated to form foam-like clusters with
micrometer sizes [44].

5.7. Raman spectroscopy
Most of APIs are more polarisable and they tend
to produce strong Raman bands as compared to the
excipients. The IR spectrum generally covers a lowfrequency range of about 4000 cm1. Raman used to
determine any change in the chemical structure,
formation of new molecules, and/or formation of
chemical or physical interaction in the eutectic
solution. Raman bands which are produced by
amorphous substances are broad and below
400cm-1 and show a tendency to disappear [42]. In
pharmaceuticals, raman spectroscopy is appropriate
for investigation of single crystals, powders or lump
of substances. Transmission raman spectioscopy is
reliable to analyse polymorphic content in bulk
samples. Two types of instruments are used for
raman measurements one is dispersive spectrometer and another is fourier transform spectrometer.
The dispersive spectrometer involves a visible
region, gratings and detectors (silicon charged

6. Applications of eutectic Mixtures in the
pharmaceutical industry
The eutectic system was used in the pharmaceutical ﬁeld as the best alternative choice to boost the
solubility regarding poorly water-soluble drugs,
absorption and permeation, or applying as an oil
phase in an emulsion system [45]. Since it is
affordable, biodegradable, nonﬂammable, and nontoxic, the system of liquid eutectic made of quaternary ammonium salts and organic component was
utilized as deep eutectic solvent (DES) [38,46]. There
are a variety of pharmaceutical actions that use
compounds that are used as eutectic components,
including pain relief, local anesthetic, antiﬂatulent,
antipuritic, and antimicrobials. Menthol works
similarly as a permeation enhancer. By mixing
menthol and camphor for forming a liquid eutectic
that could be used as an analgesic and an anti-inﬂammatory at room temperature [47e49].
Excipient selection during the pre-formulation
role is critically inﬂuenced by studies on the
compatibility of excipients and drugs, which could
assist anticipate potential physical incompatibilities
between drug and excipient molecules [50]. EM is
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used to extract and purify a small number of
compounds, including natural products and metabolites. Extraction media are DES. A two-step
extraction approach is as follows: (i) the capability of
DES to better solubilize the target compound than
source tissues or a chemically complex matrix,
which is considered a pro for DES as extraction
media [51]. EMs are frequently employed in the
development and distribution of pharmaceuticals
for a variety of administration routes, including
transdermal drug delivery. EM is used in the production of pharmaceutical dosage forms to help
prevent manufacturing problems. For instance,
during tablet compaction, the heat generated in the
punch and die cavities might cause the tablet powder compacts to fuse or melting, resulting in
manufacturing defects [52]. EM could be used to
detect substances like ergotamine and allobarbital
that have identical melting points but a differing
eutectic point [7]. EMs have a signiﬁcant role in
enhancing the skin penetration of topical formulations for poorly soluble drugs, leading to reduced
treatment effects, quicker drug delivery to the target
location, and higher tissue drug levels [5]. The
capability of the drug to maintain its form in a
speciﬁc environment, such as under biological
conditions, was improved by the application of EMs
[53]. Many structural or external elements, such as
temperature, light, oxidation, pH, or enzymes, have
an impact on stability. For instance, after a
prolonged period of storage in water, many estercontaining APIs, such as aspirin, might undergo
hydrolysis [54]. Compared with the stability of APIs
in aqueous media, EM has been demonstrated to be
vital solvent to increase the chemical stability of
these solvents [55,56].

primarily created crystalline EM to address this
disadvantage. Simple, inexpensive techniques that
are simple to scale up could be used to prepare
additional EMs.
Additionally, EMs allow the blending of therapeutically suitable active pharmacological ingredients (drugedrug EMs) for creating ﬁxed-dose
combined systems. As a result, EMs offer a promising way to enhance the properties, therapeutic
effect, and delivery of drugs. The drawbacks of Ems
are associated with the characterization challenges
that deter researchers from this straightforward
system because it is still complicated to employ
technologies that can get a better knowledge of
eutectic mixtures, which calls for more research.
Lately, several researchers have become interested
in the creation of solid dosage forms containing
EMs. To expand the EMs on a commercial level,
signiﬁcant attempts are required. The pharmaceutical ﬁeld will have a wide range of prospects thanks
to EMs, and the previously reported positive studies
will keep motivating researchers to expand their use
in other claims.
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7. Conclusion
In time to improve the solubility of weakly watersoluble drugs used in oral therapy, EMs have long
been recognized. However, there has been a signiﬁcant number in publications over the past few
years. These straightforward EMs have also
demonstrated promise as strategies for enhancing
drug solubility. Solid dispersion and EM are contrasted. It is thought that the crystalline form of EM
components has advantages over the amorphous
form of solid dispersion. The amorphous form has a
tendency to recrystallize, especially under high
humidity conditions during manufacture, storage,
or dissolution, which is viewed as a concern even if
it signiﬁcantly enhances the pace of dissolution in
comparison with the crystalline complement. Since
EM already exists in crystalline form, researchers
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